Tribute Pharmaceuticals Canada Inc. Operating Income
Tribute Pharmaceuticals Canada Inc. reported Operating Income of $107.17 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2011-11-14
- Tribute Pharmaceuticals Canada Inc. operating income (loss) for the quarter ending 2011-09-30 was $107.17K, a 92.22% decline year-over-year.
- Tribute Pharmaceuticals Canada Inc. operating income (loss) for the quarter ending 2011-06-30 was $55.04K, a 84.68% decline year-over-year.
- Tribute Pharmaceuticals Canada Inc. operating income (loss) for the quarter ending 2010-09-30 was $1.38M.
- Tribute Pharmaceuticals Canada Inc. operating income (loss) for the quarter ending 2010-06-30 was $359.17K.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month |
|---|---|---|---|
| 2011-09-30 | $107.17K 10-Q · filed 2011-11-14 | $162.21K derived: sum of 2 quarters · filed 2011-11-14 | -$144.17K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $55.04K 10-Q/A · filed 2011-08-22 | -$251.34K 10-Q/A · filed 2011-08-22 | |
| 2010-09-30 | $1.38M 10-Q · filed 2011-11-14 | $1.74M derived: sum of 2 quarters · filed 2011-11-14 | $1.50M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $359.17K 10-Q/A · filed 2011-08-22 | $125.42K 10-Q/A · filed 2011-08-22 |